APAC Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030

APAC Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030

Asia-Pacific Brain Cancer Diagnostic Market, By Test Type (Imaging Test, Biopsy, Lumber Puncture, Molecular Testing, Electroencephalography (EEG), and Others), Cancer Type (Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others, Country (China, Japan, South Korea, India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Australia, and the rest of Asia-Pacific), Industry Trends and Forecast to 2030.

Market Definition

Brain cancer is an overgrowth of cells in the brain that forms masses called tumors. It is a brain disorder in which cancer cells (malignant cells) arise in the brain tissue. Cancer cells multiply to produce a mass of cancer tissue (tumor) that interferes with brain functions such as muscle control, sensation, memory, and other body functions. Cancer cells that arise from brain tissue are called primary brain tumors, while tumors that spread from other parts of the body to the brain are called metastatic or secondary brain tumors.

Primary brain tumors can develop from a variety of brain tissues (for example, glial cells, astrocytes, and other brain cell types). Metastatic brain cancer is caused by the spread of cancer cells from a body organ to the brain.

Market Segmentation

The Asia-Pacific brain cancer diagnostic market is categorized into four notable segments: test type, cancer type, age group and end user.
• On the basis of test type, the Asia-Pacific brain cancer diagnostics market is segmented into imaging tests, biopsy, lumber puncture, molecular testing, electroencephalography(EEG), and others
• On the basis of cancer type, the Asia-Pacific brain cancer diagnostics market is segmented into acoustic neuroma, astrocytomas, glioblastoma multiforme, meningiomas, oligodendroglioma, and others
• On the basis of age group, the Asia-Pacific brain cancer diagnostics market is segmented into below 21, 21-34,35-65, and 65 and above
• On the basis of end user, the Asia-Pacific brain cancer diagnostics market is segmented into hospitals, specialty clinics, diagnostic centers and research institutes, ambulatory surgical centers, and others

Market Players

Some of the key market players in Asia-Pacific brain diagnostic market are listed below:
• NIHON KOHDEN CORPORATION.
• FUJIFILM Holdings Corporation
• GE HealthCare
• Koninklijke Philips N.V.
• BD
• Siemens Healthcare GmbH
• Canon Inc.
• Others